Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction
Journal of Clinical Medicine · 22.02.2024 · 13 (5) · 1256
DOI: 10.3390/jcm13051256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.02.2024. Verfasst von Federica Marchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione CNR-Regione Toscana Gabriele Monasterio, Ospedale G Pasquinucci, 54100 Massa, Italy. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
The systemic inflammatory response index (SIRI; neutrophil count × monocyte/lymphocyte count), and the systemic immune-inflammation index (SII; platelet count × neutrophil count/lymphocyte count) are recently proposed biomarkers to assess the immune and inflammatory status. However, data on SIRI and SII are still relatively lacking and do not definitively and exhaustively define their role as predictors of an adverse prognosis in acute myocardial infarction (AMI). The aim of the present study was to evaluate SII and SIRI determinants as well as to assess SIRI and SII prognostic power in ST-elevation myocardial infarction (STEMI). (2)
Methods
A total of 105 STEMI patients (74 males, 70 ± 11 years) were studied (median follow-up 54 ± 25 months, 24 deaths). (3)
Results
The main determinants of SIRI and SII were creatinine and brain natriuretic peptide (BNP) (multivariate regression). Patients with higher SIRI (>75th percentile, 4.9) and SII (>75th percentile, 1257.5) had lower survival rates than those in the low SIRI/SII group (Kaplan–Meier analysis). Univariate Cox regression revealed that high SIRI and SII were associated with mortality (HR: 2.6, 95% CI: 1.1–5.8, p < 0.05; 2.2, 1–4.9, p ≤ 0.05, respectively); however, these associations lost their significance after multivariate adjustment. (4)
Conclusions
SIRI and SII association with mortality was significantly affected by confounding factors in our population, especially creatinine and BNP, which are associated with both the inflammatory indices and the outcome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fondazione CNR-Regione Toscana Gabriele Monasterio, Ospedale G Pasquinucci, 54100 Massa, Italy.
- Institute of Clinical Physiology, National Research Council, Via G. Moruzzi 1, 56124 Pisa, Italy.
- Fondazione CNR-Regione Toscana G Monasterio, Via G. Moruzzi 1, 56124 Pisa, Italy.
ORCID-Profile: Melania Gaggini, Sergio Berti, Cristina Vassalle
Zitieren
APA
Marchi, F., Pylypiv, N., Parlanti, A., Storti, S., Gaggini, M., Paradossi, U., Berti, S., & Vassalle, C. (2024). Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction. Journal of Clinical Medicine, 13(5), 1256. https://doi.org/10.3390/jcm13051256
Vancouver
Marchi F, Pylypiv N, Parlanti A, Storti S, Gaggini M, Paradossi U, et al. Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction. Journal of Clinical Medicine. 2024;13(5):1256. doi:10.3390/jcm13051256
BibTeX
@article{Marchi2024,
author = {Marchi, Federica and Pylypiv, Nataliya and Parlanti, Alessandra and Storti, Simona and Gaggini, Melania and Paradossi, Umberto and Berti, Sergio and Vassalle, Cristina},
title = {Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {5},
pages = {1256},
doi = {10.3390/jcm13051256}
}
EUVIMED